Jingkai Wang

Jingkai Wang

Auto-generated profile, based on publicly available information

Jingkai Wang

Department of Orthopedics Second Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Bioactive Materials
Verified
Journal Article
Open access
CWChenggui Wang
Chenggui Wang
MWMin Wang
Min Wang
KXKaishun Xia
Kaishun Xia
JWJingkai Wang
Jingkai Wang
FCFeng Cheng
Feng Cheng
QCQixin Chen
Qixin Chen
The repair and motor functional recovery after spinal cord injury (SCI) remains a worldwide challenge. The inflammatory microenvironment is one of main obstacles on inhibiting the recovery of SCI. Using mesenchymal stem cells (MSCs) derived extracellular vesicles to replace MSCs transplantation and mimic cell paracrine secretions provides a potential strategy for microenvironment regulation. However, the effective preservation and controlled release of extracellular vesicles in the injured spinal cord tissue are still not satisfied. Herein, we fabricated an injectable adhesive anti-inflammatory F127-polycitrate-polyethyleneimine hydrogel (FE) with sustainable and long term extracellular vesicle release (FE@EVs) for improving motor functional recovery after SCI. The orthotopic injection of FE@EVs hydrogel could encapsulate extracellular vesicles on the injured spinal cord, thereby synergistically induce efficient integrated regulation through suppressing fibrotic scar formation, reducing inflammatory reaction, promoting remyelination and axonal regeneration. This study showed that combining extracellular vesicles into bioactive multifunctional hydrogel should have great potential in achieving satisfactory locomotor recovery of central nervous system diseases.

23 December 2021 in Bioactive Materials
Verified
Journal Article
Open access
BYBiao Yang
Biao Yang
CLChengzhen Liang
Chengzhen Liang
DCDi Chen
Di Chen
FCFeng Cheng
Feng Cheng
YZYuang Zhang
Yuang Zhang
QCQixin Chen
Qixin Chen
The current effective method for treatment of spinal cord injury (SCI) is to reconstruct the biological microenvironment by filling the injured cavity area and increasing neuronal differentiation of neural stem cells (NSCs) to repair SCI. However, the method is characterized by several challenges including irregular wounds, and mechanical and electrical mismatch of the material-tissue interface. In the current study, a unique and facile agarose/gelatin/polypyrrole (Aga/Gel/PPy, AGP3) hydrogel with similar conductivity and modulus as the spinal cord was developed by altering the concentration of Aga and PPy. The gelation occurred through non-covalent interactions, and the physically crosslinked features made the AGP3 hydrogels injectable. In vitro cultures showed that AGP3 hydrogel exhibited excellent biocompatibility, and promoted differentiation of NSCs toward neurons whereas it inhibited over-proliferation of astrocytes. The in vivo implanted AGP3 hydrogel completely covered the tissue defects and reduced injured cavity areas. In vivo studies further showed that the AGP3 hydrogel provided a biocompatible microenvironment for promoting endogenous neurogenesis rather than glial fibrosis formation, resulting in significant functional recovery. RNA sequencing analysis further indicated that AGP3 hydrogel significantly modulated expression of neurogenesis-related genes through intracellular Ca2+ signaling cascades. Overall, this supramolecular strategy produces AGP3 hydrogel that can be used as favorable biomaterials for SCI repair by filling the cavity and imitating the physiological properties of the spinal cord.

11 November 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LMLongfei Ma
Longfei Ma
LYLina Yu
Lina Yu
BJBao-Chun Jiang
Bao-Chun Jiang
JWJingkai Wang
Jingkai Wang
XGXinying Guo
Xinying Guo
MYMin Yan
Min Yan
Nerve injury–induced changes of gene expression in dorsal root ganglion (DRG) are critical for neuropathic pain genesis. However, how these changes occur remains elusive. Here we report the down-regulation of zinc finger protein 382 (ZNF382) in injured DRG neurons after nerve injury. Rescuing this down-regulation attenuates nociceptive hypersensitivity. Conversely, mimicking this down-regulation produces neuropathic pain symptoms, which are alleviated by C-X-C motif chemokine 13 (CXCL13) knockdown or its receptor CXCR5 knockout. Mechanistically, an identified cis-acting silencer at distal upstream of the Cxcl13 promoter suppresses Cxcl13 transcription via binding to ZNF382. Blocking this binding or genetically deleting this silencer abolishes the ZNF382 suppression on Cxcl13 transcription and impairs ZNF382-induced antinociception. Moreover, ZNF382 down-regulation disrupts the repressive epigenetic complex containing histone deacetylase 1 and SET domain bifurcated 1 at the silencer-promoter loop, resulting in Cxcl13 transcriptional activation. Thus, ZNF382 down-regulation is required for neuropathic pain likely through silencer-based epigenetic disinhibition of CXCL13, a key neuropathic pain player, in DRG neurons.

31 January 2020 in Small
Verified
Journal Article
Closed access
PDF file
JWJingkai Wang
Jingkai Wang
DLDongdong Li
Dongdong Li
CLChengzhen Liang
Chengzhen Liang
CWChenggui Wang
Chenggui Wang
XZXiaopeng Zhou
Xiaopeng Zhou
YSYouqing Shen
Youqing Shen

19 August 2016 in Experimental Biology and Medicine
Verified
Journal Article
Open access
PDF file
JWJingkai Wang
Jingkai Wang
YTYiqing Tao
Yiqing Tao
XZXiaopeng Zhou
Xiaopeng Zhou
HLHao Li
Hao Li
CLChengzhen Liang
Chengzhen Liang
QCQixin Chen
Qixin Chen
Recent studies indicated that cell-based therapy could be a promising approach to treat intervertebral disc degeneration. Though the harsh microenvironment in disc is still challenging to implanted cells, it could be overcome by pre-conditioning graft cells before transplantation, suggested by previous literatures. Therefore, we designed this study to identify the potential effect of chondrogenic pre-differentiation on adipose-derived mesenchymal stem cells in intervertebral disc-like microenvironment, characterized by limited nutrition, acidic, and high osmosis in vitro. Adipose-derived mesenchymal stem cells of rat were divided into five groups, embedded in type II collagen scaffold, and cultured in chondrogenic differentiation medium for 0, 3, 7, 10, and 14 days. Then, the adipose-derived mesenchymal stem cells were implanted and cultured in intervertebral disc-like condition. The proliferation and differentiation of adipose-derived mesenchymal stem cells were evaluated by cell counting kit-8 test, real-time quantitative polymerase chain reaction, and Western blotting and immunofluorescence analysis. Analyzed by the first week in intervertebral disc-like condition, the results showed relatively greater proliferative capability and extracellular matrix synthesis ability of the adipose-derived mesenchymal stem cells pre-differentiated for 7 and 10 days than the control. We concluded that pre-differentiation of rat adipose-derived mesenchymal stem cells in chondrogenic culture medium for 7 to 10 days could promote the regeneration effect of adipose-derived mesenchymal stem cells in intervertebral disc-like condition, and the pre-differentiated cells could be a promising cell source for disc regeneration medicine.

11 March 2022 in Biomaterials
Verified
Journal Article
Closed access
LYLiwei Ying
Liwei Ying
CLChengzhen Liang
Chengzhen Liang
YZYujie Zhang
Yujie Zhang
JWJingkai Wang
Jingkai Wang
CWChenggui Wang
Chenggui Wang
QCQixin Chen
Qixin Chen